Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Pooled Analysis of Complete Remission Among Pediatric Patients With Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

NCT02303522 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02303522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Pooled Analysis of Complete Remission Among Pediatric Patients With Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
December 9, 2014
Completion date
January 22, 2015
Enrollment
207 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell precursor acute lymphoblastic leukemia (all)